Oseltamivir phosphate for suspension is bioequivalent to TAMIFLU in healthy volunteers: a randomized, open-label clinical study

PURPOSE: The study was aimed at evaluating the bioequivalence and safety of oseltamivir phosphate for suspension, provided by Shenzhen Beimei Pharmaceutical Co. Ltd. and manufactured by Hetero Labs Limited, and the reference product TAMIFLU® in healthy Chinese subjects. METHODS: A single-dose, rando...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Ying, Tang, Bangzhong, Xie, Jing, Wang, Xiaoqin, Ren, Peng, Wu, Guangmei, He, Cuixia, Zhu, Minhui, Su, Yue, Ding, Jiaxiang, Xu, Yuanyuan, Fan, Ling, Ge, Qin, Ding, Yuzhou, Zhu, Juan, Liu, Bingyan, Shan, Rongfang, Zhou, Huan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9942619/
https://www.ncbi.nlm.nih.gov/pubmed/36810140
http://dx.doi.org/10.1186/s40360-023-00646-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9942619/
https://www.ncbi.nlm.nih.gov/pubmed/36810140
http://dx.doi.org/10.1186/s40360-023-00646-1

Ejemplares similares